Sarah Cannon at University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Cancer treatment center in Oklahoma City, Oklahoma
800 NE 10th St, Oklahoma City, OK 73104
About Sarah Cannon at University of Oklahoma Health Sciences Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ADC Therapeutics S.A.
2
Clinical Trials at Sarah Cannon at University of Oklahoma Health Sciences Center
During the past decade, Sarah Cannon at University of Oklahoma Health Sciences Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors
2021-09-09
2025-04-05
Recruiting
76
A Dose-Escalation and Dose-Expansion Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors
2022-07-13
2027-08-01
Recruiting
66
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sarah Cannon at University of Oklahoma Health Sciences Center
According to Clinical.Site data, the most researched conditions in "Sarah Cannon at University of Oklahoma Health Sciences Center" are
"Advanced Solid Tumors" (2 trials). Many other conditions were trialed in "Sarah Cannon at University of Oklahoma Health Sciences Center" in a lesser frequency.
Clinical Trials Intervention Types at Sarah Cannon at University of Oklahoma Health Sciences Center
Most popular intervention types in "Sarah Cannon at University of Oklahoma Health Sciences Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "ADCT-601" (1 trials), "ADCT-901" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sarah Cannon at University of Oklahoma Health Sciences Center
The vast majority of trials in "Sarah Cannon at University of Oklahoma Health Sciences Center" are
2 trials for "All" genders.
Clinical Trials Status at Sarah Cannon at University of Oklahoma Health Sciences Center
Currently, there are NaN active trials in "Sarah Cannon at University of Oklahoma Health Sciences Center".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Sarah Cannon at University of Oklahoma Health Sciences Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Sarah Cannon at University of Oklahoma Health Sciences Center, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".